News
Market Momentum: Bioxcel (BTAI) Stocks Rise On Regulatory Developments And Equity Strategy Shift
BioXcel Therapeutics, Inc. (NASDAQ: BTAI) observed a substantial increase in its stock value, rising by 26.02% in the prior trading
Menu